Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Jun 07, 2017 11:35 AM IST | Source: PTI

Unichem Lab gets EIR from USFDA for Ghaziabad formulation unit

"The company's formulations manufacturing facility at Ghaziabad has received an establishment inspection report (EIR) from the USFDA. This receipt indicates the successful closure of the inspection and the queries raised during the audit (Form 483)," Unichem Laboratories said in a BSE filing.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Unichem Laboratories today said it has received an establishment inspection report from the US health regulator for its formulation manufacturing facility in Ghaziabad.

"The company's formulations manufacturing facility at Ghaziabad has received an establishment inspection report (EIR) from the USFDA. This receipt indicates the successful closure of the inspection and the queries raised during the audit (Form 483)," Unichem Laboratories said in a BSE filing.

It further said: "The inspection has now been closed by the USFDA. The inspection was carried out between February 24, 2017 and March 3, 2017."

The USFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed.

The stock of company was trading at Rs 249.50 apiece, up 1.07 per cent from its previous close on the BSE.
First Published on Jun 7, 2017 11:21 am
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant